Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer

Pamela J. Goodwin, Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Hobday, Judith M. Bliss, Priya Rastogi, Manuela Rabaglio-Poretti, Som D. Mukherjee, John R. Mackey, Vandana G. Abramson, Conrad Oja, Robert Wesolowski, Alastair M. Thompson, Daniel W. Rea, Paul M. Stos, Lois E. Shepherd, Vuk Stambolic, Wendy R. Parulekar

Open source

DOI: 10.1001/jama.2022.6147
Published: 2022-05-24
Container: JAMA
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jama.2022.6147,
  title = {Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer},
  author = {Pamela J. Goodwin and Bingshu E. Chen and Karen A. Gelmon and Timothy J. Whelan and Marguerite Ennis and Julie Lemieux and Jennifer A. Ligibel and Dawn L. Hershman and Ingrid A. Mayer and Timothy J. Hobday and Judith M. Bliss and Priya Rastogi and Manuela Rabaglio-Poretti and Som D. Mukherjee and John R. Mackey and Vandana G. Abramson and Conrad Oja and Robert Wesolowski and Alastair M. Thompson and Daniel W. Rea and Paul M. Stos and Lois E. Shepherd and Vuk Stambolic and Wendy R. Parulekar},
  year = {2022},
  journal = {JAMA},
  doi = {10.1001/jama.2022.6147},
  url = {https://doi.org/10.1001/jama.2022.6147}
}

RIS

TY  - JOUR
TI  - Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer
AU  - Pamela J. Goodwin
AU  - Bingshu E. Chen
AU  - Karen A. Gelmon
AU  - Timothy J. Whelan
AU  - Marguerite Ennis
AU  - Julie Lemieux
AU  - Jennifer A. Ligibel
AU  - Dawn L. Hershman
AU  - Ingrid A. Mayer
AU  - Timothy J. Hobday
AU  - Judith M. Bliss
AU  - Priya Rastogi
AU  - Manuela Rabaglio-Poretti
AU  - Som D. Mukherjee
AU  - John R. Mackey
AU  - Vandana G. Abramson
AU  - Conrad Oja
AU  - Robert Wesolowski
AU  - Alastair M. Thompson
AU  - Daniel W. Rea
AU  - Paul M. Stos
AU  - Lois E. Shepherd
AU  - Vuk Stambolic
AU  - Wendy R. Parulekar
PY  - 2022
JO  - JAMA
DO  - 10.1001/jama.2022.6147
UR  - https://doi.org/10.1001/jama.2022.6147
ER  -

APA

Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Mukherjee, S. D., Mackey, J. R., Abramson, V. G., Oja, C., Wesolowski, R., Thompson, A. M., Rea, D. W., Stos, P. M., Shepherd, L. E., Stambolic, V., & Parulekar, W. R. (2022). Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. JAMA. https://doi.org/10.1001/jama.2022.6147

Source records

crossref · retrieved 2026-09-27T11:00:51.561Z